FDA Inspection 1250728 — Denis Angoulvant
The FDA completed an inspection of Denis Angoulvant on Sep 19, 2024 in Chambray-Lestours. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 19, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Chambray-Lestours (France)
Additional Details
Clinical Investigator (CI)